newsfilter
← Latest News
GlobeNewswire·

Athenex Exits 503B Sterile Compounding Business

BUFFALO, N.Y., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of